FibroGen's P/S ratio may be low due to perceived sluggish re...

FibroGen's P/S ratio may be low due to perceived sluggish revenue performance that is unlikely to significantly improve. A slower projected revenue growth rate could further reduce the P/S ratio, potentially compromising future price appreciation.